This current work addresses the tumor-promoting effects of M2-like macrophages-derived CCL17 on the migration, invasion and stemness characteristics of ESCC cells and to thoroughly elucidate the intrinsic molecular mechanisms, aiming to develop promising targets and drugs for ESCC therapies. Here, CCL17 is linked to neoplasm.